Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Pfizer and Greek bailout fund selling as Applied Nutrition launches IPO -
Four hybrids draw attention from rampant subordinated FIG market
-
Borrowers try to slide in before ECB meets on Thursday
-
At-the-market transaction to take advantage of strong results despite volatile market
-
Novo Nordisk bought £50m of the deal leaving £30m for the market
-
Flurry of deals in euros with more to come as Monday supply already beats last week’s total volume
